Immunome Inc.·4

Mar 28, 5:54 PM ET

Higgins Jack 4

4 · Immunome Inc. · Filed Mar 28, 2025

Insider Transaction Report

Form 4
Period: 2025-03-27
Higgins Jack
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Employee Stock option (right to buy)

    2025-03-275,200173,840 total
    Exercise: $1.35Exp: 2032-06-23Common Stock (5,200 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-27$1.35/sh+5,200$7,02018,729 total
Footnotes (1)
  • [F1]25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    form4-03282025_090359.xmlPrimary